Pulmonary Pressure-Guided LVAD Control for Right Heart Failure
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing ventricular assist devices (VADs) face high mortality rates due to right heart failure (RHF), particularly in the first year post-implantation, with current strategies failing to effectively manage RHF and associated risks.
Innovation Solution
A method and system that utilizes pulmonary artery (PA) pressure measurements and trends to identify patients at risk for RHF and adjusts blood pump operating parameters, such as flow rate and mode, to prevent or reduce the onset or worsening of RHF, using regression models and real-time monitoring.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current strategies (inotropic support, preload/afterload management) are used to address RHF, then RHF management is attempted, but mortality rates remain high (20-50% of LVAD-related deaths)
Solution Approach 1:
The system performs preliminary action by monitoring PA pressure trends continuously and identifying patients at risk for RHF before clinical symptoms manifest. The regression model detects deviations from ideal pressure profiles early, allowing intervention before RHF develops or worsens, thereby preventing the 20-50% mortality rate associated with established RHF.
Solution Approach 2:
The system implements feedback by using continuous PA pressure monitoring combined with regression analysis to dynamically assess RHF risk. The system compares measured pressure trends against ideal regression models and provides real-time feedback on patient status, enabling clinicians to adjust therapy based on objective quantitative data rather than waiting for clinical deterioration.
2Object-affected harmful factors
If inotropic support is increased to manage RHF, then RHF treatment intensity is increased, but risk of mortality increases
Solution Approach 1:
The system applies preliminary anti-action by preventing RHF through early detection of pressure trend deviations. By identifying at-risk patients before RHF develops and implementing preventive therapy adjustments, the system counteracts the development of RHF rather than treating it after onset, thereby avoiding the need for intensive inotropic support that carries increased mortality risk.
Solution Approach 2:
The system performs preliminary action by proactively adjusting blood pump parameters and therapy before RHF manifests clinically. Continuous PA pressure monitoring with regression analysis enables early intervention that prevents RHF development, eliminating the need for aggressive inotropic treatment and its associated mortality risks.
3Measurement precision
If PA pressure monitoring and regression analysis are implemented, then patient risk identification improves, but device complexity increases
Solution Approach 1:
The system achieves universality by implementing a multi-functional integrated solution where a single PA pressure sensor serves multiple purposes: continuous hemodynamic monitoring, regression model input for risk prediction, and therapy guidance. This multi-functionality reduces the need for separate specialized devices while maintaining high measurement precision for RHF risk detection.
Solution Approach 2:
The system applies self-service by using the existing PA pressure monitoring infrastructure to automatically perform regression analysis and risk stratification. The system processes its own data through embedded algorithms, eliminating the need for external complex analysis equipment and enabling automated clinical decision support while maintaining measurement precision.
Data Source
AI summary
Blood pump systems include a left ventricular assist device that is controlled to inhibit onset or worsening of right ventricular failure. A blood pump system includes a left ventricular assist device, a pulmonary artery pressure sensor, and a controller. The pulmonary artery pressure sensor is configured for generating a pressure signal indicative of a blood pressure in the pulmonary artery of the patient. The controller is configured to control operation of the left ventricular assist device, process the pressure signal to generate pulmonary artery pressure data indicative of right ventricular afterload of the patient, and adjust at least one operating parameter of the left ventricular assist device based on the pulmonary artery pressure data to reduce a deviation between the right ventricular afterload of the patient and a target right ventricular afterload for the patient.